In our attempt to understand the mechanism by which RIPK4 inhibits the STAT3 pathway, we utilized publicly available data sets and patient specimen data in our study to confirm the differential expression of RIPK4 in HCC and normal liver tissues. The gene discussed is STAT3; the disease is hepatocellular carcinoma.